Debbane Raymond: insider buys
Every open-market stock purchase reported by Debbane Raymond to the SEC on Form 4.
Total bought$720.07K
Purchases3
Companies1
Last purchase filedFeb 25, 2026
Return on these buys+2.2%
Debbane Raymond has made 3 open-market purchases worth $720.07K in 1 company since Feb 18, 2026, according to SEC Form 4 filings. The most recent was filed on Feb 25, 2026: 100,000 shares of LXRX at $1.47 (Director), worth $147K. The largest was $353.07K of LXRX on Feb 13, 2026. Taken together, these purchases are up 2% at the latest closing prices (split-adjusted, weighted by amount).
Companies Debbane Raymond bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals, Inc. | Director | 3 | $720.07K | +2.2% | Feb 25 |
Get the next Debbane Raymond purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25 | LXRXLexicon Pharmaceuticals, Inc. | Debbane RaymondDirector | $147K | 100,000 | $1.47 | -3.4% | +6% | Feb 23 | SEC |
| Feb 23 | LXRXLexicon Pharmaceuticals, Inc. | Debbane RaymondDirector | $220K | 150,000 | $1.47 | -3.2% | +10% | Feb 19 | SEC |
| Feb 18 | LXRXLexicon Pharmaceuticals, Inc. | Debbane RaymondDirector | $353.07K | 268,497 | $1.31 | +8.0% | +19% | Feb 13 | SEC |